On the other hand, IL-20 promotes VEGF-mediated angiogenesis including other neuroinflammatory and autoimmune pathology: e.g., myasthenia gravis (MG) (Hsieh et al., 2006; Hammer et al., 2009; Baird et al., 2011; Aydogdu et al., 2013; Alexandrakis et al., 2015; Han et al., 2016; Kako et al., 2016; Uzawa et al., 2016; Huang et al., 2018). Here, VEGFA is linked to myasthenia gravis.